LI Jingli, LI Enli, ZHANG Chunyi, SUN Jian. Research Progress in Omega-3 in Polyunsaturated Fatty Acids in Pulmonary Diseases[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(7): 989-993. DOI: 10.13748/j.cnki.issn1007-7693.20220926
    Citation: LI Jingli, LI Enli, ZHANG Chunyi, SUN Jian. Research Progress in Omega-3 in Polyunsaturated Fatty Acids in Pulmonary Diseases[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(7): 989-993. DOI: 10.13748/j.cnki.issn1007-7693.20220926

    Research Progress in Omega-3 in Polyunsaturated Fatty Acids in Pulmonary Diseases

    • Omega-3 polyunsaturated fatty acids(ω-3 PUFA) have anti-inflammatory, antioxidant and immunomodulatory effects, the active ingredients of which include eicosapentaenoic acid and docosahexaenoic acid. Studies have shown that supplementing the diet with ω-3 PUFA has preventive and therapeutic effects on a variety of lung diseases, including acute lung injury/acute respiratory distress syndrome, asthma, chronic obstructive pulmonary disease, and lung cancer. Therefore, this article reviews the latest research progress on the effects and mechanisms of ω-3 PUFA on lung diseases, in order to provide a reference for the treatment of respiratory system diseases.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return